Aptamers News and Research

RSS
NEC, SomaLogic release professional software tool

NEC, SomaLogic release professional software tool

SomaLogic, HUNT Biosciences partner to advance clinical use of cardiovascular biomarkers

SomaLogic, HUNT Biosciences partner to advance clinical use of cardiovascular biomarkers

Gold nanostars can deliver drug directly to cancer cell nucleus

Gold nanostars can deliver drug directly to cancer cell nucleus

DNA ‘nanorobot’  effectively targets cancer leaving healthy cells untouched: Study

DNA ‘nanorobot’ effectively targets cancer leaving healthy cells untouched: Study

SomaLogic to receive TB biomarkers grant from Gates Foundation

SomaLogic to receive TB biomarkers grant from Gates Foundation

NIH awards $3.2M for development of highly efficient system of generating nucleic acid molecules

NIH awards $3.2M for development of highly efficient system of generating nucleic acid molecules

SomaLogic, Novartis enter multi-year research agreement

SomaLogic, Novartis enter multi-year research agreement

Low-cost, portable technique can detect specific proteins in human blood

Low-cost, portable technique can detect specific proteins in human blood

Regado's REG1 system Phase 2b trial results presented at i2 Summit

Regado's REG1 system Phase 2b trial results presented at i2 Summit

Regado to present REG1 Phase 2b trial results against acute coronary syndromes at i2 Summit

Regado to present REG1 Phase 2b trial results against acute coronary syndromes at i2 Summit

New approach to biomarker detection for early lung cancer diagnosis

New approach to biomarker detection for early lung cancer diagnosis

Baxter enters definitive agreement to acquire all hemophilia-related assets Archemix

Baxter enters definitive agreement to acquire all hemophilia-related assets Archemix

Regado presents poster on REG3 at AHA Scientific Sessions meeting

Regado presents poster on REG3 at AHA Scientific Sessions meeting

Regado receives funding under QTDP grant program to advance treatment for cardiovascular diseases

Regado receives funding under QTDP grant program to advance treatment for cardiovascular diseases

Dicerna secures $4 million in second closing of Series B equity financing

Dicerna secures $4 million in second closing of Series B equity financing

Researchers identify biomarkers for mesothelioma and pancreatic cancer

Researchers identify biomarkers for mesothelioma and pancreatic cancer

Emerald BioStructures, SomaLogic announce strategic collaboration for SOMAmers

Emerald BioStructures, SomaLogic announce strategic collaboration for SOMAmers

NEC, SomaLogic sign agreement to explore aptamer related businesses in life sciences, healthcare markets

NEC, SomaLogic sign agreement to explore aptamer related businesses in life sciences, healthcare markets

Dicerna announces closing of $25 million Series B round of financing

Dicerna announces closing of $25 million Series B round of financing

Texas Tech signs worldwide license agreement for metallo-beta-lactamase inhibitors with RI Scientific

Texas Tech signs worldwide license agreement for metallo-beta-lactamase inhibitors with RI Scientific